Literature DB >> 27206566

SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer.

R García-Carbonero1, R Vera2, F Rivera3, E Parlorio4, M Pagés5, E González-Flores6, C Fernández-Martos7, M Á Corral8, R Bouzas9, F Matute10.   

Abstract

Colorectal cancer (CRC) is one of the world's most common cancers, and has one of the highest mortality rates. The last few decades have seen great progress in preventing, diagnosing and treating this disease, providing undeniable impact on patients' prognosis and quality of life. At all these stages of CRC management, imaging techniques play an essential role. This article reviews some important issues concerning the use of various radiological techniques in the screening, diagnosis, staging, assessment of treatment response, and follow-up of patients with CRC. It also includes a number of practical recommendations on indications for use, technical requirements, minimum information required in the radiology report, evaluation criteria for the response to various drugs, and the recommended frequency at which different examinations should be performed. This consensus statement is the result of cooperation between the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Radiology (SERAM).

Entities:  

Keywords:  CT; Colorectal cancer; Endorectal ultrasound; Follow-up; Imaging techniques; MRI; Response evaluation; Staging

Mesh:

Year:  2016        PMID: 27206566     DOI: 10.1007/s12094-016-1518-9

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  54 in total

1.  [Prognostic factors and functional imaging in rectal cancer].

Authors:  R García Figueiras; P Caro Domínguez; R García Dorrego; A Vázquez Martín; A Gómez Caamaño
Journal:  Radiologia       Date:  2011-10-14

Review 2.  Preoperative staging of rectal cancer.

Authors:  Neil Smith; Gina Brown
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

Review 3.  Follow-up after curative resection of colorectal cancer: a meta-analysis.

Authors:  Joe J Tjandra; Miranda K Y Chan
Journal:  Dis Colon Rectum       Date:  2007-11       Impact factor: 4.585

Review 4.  Vascular endothelial growth factor-targeted therapy for the treatment of renal cell carcinoma.

Authors:  Bernard Escudier; Laurence Albiges
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

5.  Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest.

Authors:  C Cremolini; F Loupakis; C Antoniotti; S Lonardi; G Masi; L Salvatore; E Cortesi; G Tomasello; R Spadi; A Zaniboni; G Tonini; C Barone; S Vitello; R Longarini; A Bonetti; M D'Amico; S Di Donato; C Granetto; L Boni; A Falcone
Journal:  Ann Oncol       Date:  2015-02-23       Impact factor: 32.976

6.  Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study.

Authors:  Fiona G M Taylor; Philip Quirke; Richard J Heald; Brendan Moran; Lennart Blomqvist; Ian Swift; David J Sebag-Montefiore; Paris Tekkis; Gina Brown
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

7.  Can magnetic resonance imaging predict circumferential margins and TNM stage in rectal cancer?

Authors:  Graham Branagan; Helen Chave; Clare Fuller; Shaun McGee; Derek Finnis
Journal:  Dis Colon Rectum       Date:  2004-08       Impact factor: 4.585

8.  Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.

Authors:  Yun Shin Chun; Jean-Nicolas Vauthey; Piyaporn Boonsirikamchai; Dipen M Maru; Scott Kopetz; Martin Palavecino; Steven A Curley; Eddie K Abdalla; Harmeet Kaur; Chusilp Charnsangavej; Evelyne M Loyer
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

Review 9.  Magnetic resonance imaging of rectal cancer: staging and restaging evaluation.

Authors:  Courtney C Moreno; Patrick S Sullivan; Bobby T Kalb; Russell G Tipton; Krisztina Z Hanley; Hiroumi D Kitajima; W Thomas Dixon; John R Votaw; John N Oshinski; Pardeep K Mittal
Journal:  Abdom Imaging       Date:  2015-10

10.  Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107.

Authors:  Axel Grothey; Eric E Hedrick; Robert D Mass; Somnath Sarkar; Sam Suzuki; Ramesh K Ramanathan; Herbert I Hurwitz; Richard M Goldberg; Daniel J Sargent
Journal:  J Clin Oncol       Date:  2008-01-10       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.